Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inflammation markers in daily practice].

F Le Roy1, S Barbier, E Martin Passos

  • 1Service de néphrologie, Centre hospitalier universitaire de Rouen. Frank.Le-Roy@chu-rouen.fr

Nephrologie
|December 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-thaw embryo culture and the risk of large-for-gestational-age offspring: a retrospective cohort study.

Reproductive health·2026
Same author

Compliance with good practice guidelines for the prevention of vascular access infections: the multi-centre PHYDEL survey in French haemodialysis units.

The Journal of hospital infection·2023
Same author

Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination.

Human reproduction (Oxford, England)·2021
Same author

[Hot issues in bifurcation lesions PCI in 2019].

Annales de cardiologie et d'angeiologie·2019
Same author

Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Immune Reconstitution Inflammatory Syndrome Secondary to Mycobacterium kansasii Infection in a Kidney Transplant Recipient.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same journal

Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment.

Nephrologie·2004
Same journal

[Acute renal failure and 2,8-dihydroxyadeninuria].

Nephrologie·2004
Same journal

[Phototherapy and hemodialysis pruritus].

Nephrologie·2004
Same journal

[Pregnancy and hemodialysis].

Nephrologie·2004
Same journal

[Role of dietary fibers in the nutritional management of chronic renal failure].

Nephrologie·2004
Same journal

[Abstracts of the VI Meeting of the Society of Nephrology and of the Francophone Society of Dialysis. Marseille, France, 28 September-1 October 2004].

Nephrologie·2004
See all related articles

Inflammation markers like C-reactive protein and procalcitonin can help manage hemodialysis patients by predicting mortality and detecting infections. Early detection improves patient outcomes and treatment strategies.

Area of Science:

  • Nephrology
  • Clinical Chemistry
  • Infectious Diseases

Background:

  • Cardiovascular diseases and infections are leading causes of mortality in End-Stage Renal Disease (ESRD) patients.
  • European guidelines recommend using inflammation markers in daily hemodialysis practice.
  • These markers predict cardiovascular and overall mortality and aid in detecting silent infections.

Purpose of the Study:

  • To highlight the importance of inflammation markers in managing ESRD patients undergoing hemodialysis.
  • To emphasize the role of C-reactive protein and procalcitonin in improving diagnostic and therapeutic strategies.

Main Methods:

  • Review of current clinical practice and recommendations in hemodialysis.
  • Discussion of the utility of C-reactive protein as a general inflammation marker.

Related Experiment Videos

  • Emphasis on the specific role of procalcitonin in identifying bacterial infections.

    • Main Results:

    • Inflammation markers effectively predict mortality in ESRD patients.
    • These markers assist in identifying subclinical infections (e.g., parodontitis, H. pylori, shunt infections).
    • Inflammation markers contribute to assessing dialysis biocompatibility.

    Conclusions:

    • Combining C-reactive protein and procalcitonin measurements can enhance diagnostic and therapeutic strategies for hemodialysis patients.
    • Routine monitoring of inflammation markers is crucial for improving patient care and outcomes in ESRD.